International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(3), P. 2236 - 2236
Published: Jan. 23, 2023
Cancer
is
characterized
by
persistent
cell
proliferation
driven
aberrant
cycle
regulation
and
stimulation
of
cyclin-dependent
kinases
(CDKs).
A
very
intriguing
potential
approach
for
the
development
antitumor
medicines
suppression
CDKs
that
lead
to
induction
apoptosis
arrest.
The
shift
from
G0/G1
phase
S
phase,
which
active
transcription
synthesis,
depends
on
cyclin
D-CDK4/6
complex.
precise
balance
between
anticancer
activity
general
toxicity
demonstrated
CDK
inhibitors,
can
specifically
block
CDK4/6
control
reducing
G1
transition.
inhibitors
have
recently
been
reported
exhibit
significant
growth
inhibition
via
modulating
tumour
microenvironment
in
cancerous
cells.
One
new
understanding
these
serve
important
functions
interaction
among
cells
host
immune
system
addition
being
cytostatic.
Herein,
we
discuss
biological
significance
cancer
therapeutics,
as
well
their
impact
T
other
Furthermore,
explore
integration
preclinical
findings
pharmaceuticals'
ability
enhance
immunity.
Cancers,
Journal Year:
2021,
Volume and Issue:
13(22), P. 5741 - 5741
Published: Nov. 16, 2021
Cannabinoid
receptors,
which
are
widely
distributed
in
the
body,
have
been
considered
as
possible
pharmacological
targets
for
management
of
several
tumors.
type
2
receptors
(CB2Rs)
belong
to
G
protein-coupled
receptor
family
and
mainly
expressed
hematopoietic
immune
cells,
such
B-cells,
T-cells,
macrophages;
thus,
CB2R
activation
might
be
useful
treating
cancers
affecting
plasma
multiple
myeloma
(MM).
Previous
studies
shown
that
stimulation
may
anti-proliferative
effects;
therefore,
purpose
present
study
was
explore
antitumor
effect
beta-caryophyllene
(BCP),
a
agonist,
an
vitro
model
MM.
Dexamethasone-resistant
(MM.1R)
sensitive
(MM.1S)
human
cell
lines
were
used
this
study.
Cells
treated
with
different
concentrations
BCP
24
h,
group
cells
pre-incubated
AM630,
specific
antagonist.
treatment
reduced
proliferation
through
stimulation;
notably,
considerably
increased
pro-apoptotic
protein
Bax
decreased
anti-apoptotic
molecule
Bcl-2.
Furthermore,
increase
caspase
3
levels
detected
following
incubation,
thus
demonstrating
its
apoptosis
activation.
In
addition,
regulated
AKT,
Wnt1,
beta-catenin
expression,
showing
decrease
cancer
by
modulating
Wnt/β-catenin
signaling.
These
effects
counteracted
AM630
co-incubation,
confirming
BCP's
mechanism
action
is
related
modulation.
A
β-catenin
impaired
cycle
especially
promoted
cyclin
D1
CDK
4/6
reduction.
Taken
together,
these
data
revealed
significant
effective
anti-cancer
MM
activating
apoptosis,
molecular
pathways,
downregulating
cycle.
Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
12(2), P. 572 - 572
Published: Jan. 10, 2023
Cyclin
D1
is
mainly
known
as
an
oncogenic
driver
in
cancers,
and
the
dysregulated
cyclin
D1/cyclin-dependent
kinase
(CDK)
4/6
axis
considered
attractive
target
for
cancer
therapy.
Recent
studies
have
reported
that
tumors
respond
to
therapeutic
interventions
targeting
altered
expression
via
application
of
CDK4/6
inhibitor.
However,
prognostic
contributions
colorectal
(CRC)
remain
controversial.
Herein,
we
assessed
associations
between
clinicopathological
factors,
including
patients'
overall
survival
(OS)
recurrence-free
(RFS),
495
surgically
resected
primary
CRCs.
We
also
examined
previous
High
expressions
(cyclin
D1High)
was
observed
389
CRC
cases
(78.6%).
D1High
consistently
predicted
better
patient
OS
RFS
Based
on
multivariate
analysis,
young
age
patients
remained
independent
prognosticators
higher
rate,
whereas
D1High,
females,
chemotherapy,
absence
nodal
metastasis,
lower
T-category
RFS.
commonly
overexpressed
CRCs,
its
can
be
used
a
favorable
indicator
with
CRCs;
this
may
important
predicting
responses
subsequent
inhibitors.
BMC Complementary Medicine and Therapies,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: April 25, 2023
Abstract
Background
Apitherapy
is
an
emerging
field
in
cancer
research,
particularly
developing
communities.
The
potency
of
Melittin
(MEL),
a
major
constituent
bee
venom
accounted
for
the
cytotoxic
capacity
against
cells.
It
postulated
that
genotype
bees
and
time
collection
influences
its
specific
activity
certain
types
cancer.
Method
Hereby,
Jordanian
crude
(JCBV)
was
collected
during
different
seasons
year,
specifically
spring,
summer
autumn
investigated
vitro
antitumour
effects.
Venom
springtime
comprised
highest
quantity
MEL
comparison
to
some
other
time.
Springtime-collected
JCBV
extract
were
tested
on
immortal
myelogenous
leukaemia
cell
line,
namely
K562
leukemic
Treated
cells
examined
modality
via
flow
cytometry
analysis
death
mediating
gene
expressions.
Results
showed
IC
50
3.7
±
0.37
μg/ml
1.84
0.75
μg/ml,
respectively.
In
positive
control,
MEL-treated
exhibited
late
apoptotic
with
moderate
cellular
arrest
at
G0/G1
increase
number
G2/M
phase.
Expression
NF-κB/MAPK14
axis
inhibited
JCBV-treated
cells,
as
well
expression
c-MYC
CDK4.
Moreover,
marked
upregulation
ABL1,
JUN
TNF
observed.
conclusion,
springtime-collected
content
while
both
pure
apoptotic,
necrotic,
cycle
efficiency
Conclusion
Integration
chemotherapy
needs
more
investigation
should
be
carefully
translated
into
clinical
use.
During
such
translation,
correlation
genotype,
concentration
CBV
profiled.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(3), P. 2236 - 2236
Published: Jan. 23, 2023
Cancer
is
characterized
by
persistent
cell
proliferation
driven
aberrant
cycle
regulation
and
stimulation
of
cyclin-dependent
kinases
(CDKs).
A
very
intriguing
potential
approach
for
the
development
antitumor
medicines
suppression
CDKs
that
lead
to
induction
apoptosis
arrest.
The
shift
from
G0/G1
phase
S
phase,
which
active
transcription
synthesis,
depends
on
cyclin
D-CDK4/6
complex.
precise
balance
between
anticancer
activity
general
toxicity
demonstrated
CDK
inhibitors,
can
specifically
block
CDK4/6
control
reducing
G1
transition.
inhibitors
have
recently
been
reported
exhibit
significant
growth
inhibition
via
modulating
tumour
microenvironment
in
cancerous
cells.
One
new
understanding
these
serve
important
functions
interaction
among
cells
host
immune
system
addition
being
cytostatic.
Herein,
we
discuss
biological
significance
cancer
therapeutics,
as
well
their
impact
T
other
Furthermore,
explore
integration
preclinical
findings
pharmaceuticals'
ability
enhance
immunity.